Purpose Management of contraception in adolescent females with hormone-related venous
thromboembolism (VTE) is challenging. We examined the characteristics of this patient …

STUDY OBJECTIVE: To define the thrombotic risk factors of young women presenting to a
children's hospital with hormonal contraception-related venous thromboembolism (VTE). We …

Venous thromboembolism (VTE) is a rare but serious complication of combined hormonal
contraception. While the absolute risk of VTE is low in adolescents, thrombotic events in …

Background The number of adolescents who are prescribed hormonal contraception (HC)
for contraceptive and noncontraceptive indications is increasing. Approximately 1 of 4 …

Abstract Study Objective Our goal was to describe the period prevalence of venous
thromboembolism (VTE) and characterize adolescent female patients diagnosed with VTE …

Background: Venous thromboembolism (VTE) is rare among young women and is often
presumed to occur in the setting of a genetic predisposition or during the use of estrogen …

Sex matters when it comes to venous thromboembolism (VTE). We defined 5P's–period, pill,
prognosis, pregnancy, and postthrombotic syndrome–that should be discussed with young …

In this short review, I will describe the epidemiology of hormone-related venous
thromboembolism (VTE). In particular, the impact of hormones for women who have an …

Context Hormone-dependent gynaecological disorders, such as polycystic ovary syndrome
(PCOS) or endometriosis, have been recently discussed as potential risk factors for venous …

There is scarce information on the clinical characteristics of contraceptive users who
develop venous thromboembolism (VTE). RIETE is an ongoing registry of consecutive …